Showing results (21-30 of 97) with videos related to

Sort By:
Pageof 10
Leukemia Research|March 16, 2010
FISH analysis of circulating CD34+ cells as a new tool for genetic monitoring in MDS: verification of the method and application to 27 MDS patientsFriederike Braulke, Julie Schanz, Klaus Jung, et al.
European Journal of Haematology|March 30, 2026
Long-Term Clinical and Molecular Dynamics in Hypoplastic Myelodysplastic Neoplasia Treated With Immunosuppressive TherapyHannes Treiber, Christina Ganster, Katayoon Shirneshan, et al.
Genes, Chromosomes & Cancer|July 8, 2005
A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11.2) translocation in a patient with a clinically typical chronic myeloid leukemiaFrank Griesinger, Heike Hennig, Frauke Hillmer, et al.
Haematologica|November 3, 2009
ABC transporter A3 facilitates lysosomal sequestration of imatinib and modulates susceptibility of chronic myeloid leukemia cell lines to this drugBjoern Chapuy, Melanie Panse, Ulf Radunski, et al.
Tissue Engineering|September 15, 2004
Mesengenic progenitor cells derived from human placentaGerald G Wulf, Volker Viereck, Bernhard Hemmerlein, et al.
Journal of Blood Medicine|June 30, 2025
Real-World Treatment Patterns, Clinical Outcomes, and Costs in Patients with Higher-Risk Myelodysplastic Syndromes Across France, Germany, and the United KingdomMark Drummond, Carlo Finelli, Fjoralba Kristo, et al.
Current Oncology (Toronto, Ont.)|January 20, 2023
Fatal Progression of Mutated TP53-Associated Clonal Hematopoiesis following Anti-CD19 CAR-T Cell TherapyLea Naomi Eder, Danilo Martinovic, Paolo Mazzeo, et al.
Annals of Hematology|June 23, 2010
Azacitidine for treatment of patients with myelodysplastic syndromes (MDS): practical recommendations of the German MDS Study GroupKatharina Götze, Uwe Platzbecker, Aristoteles Giagounidis, et al.
Therapeutic Drug Monitoring|September 14, 2011
Use of total and unbound imatinib and metabolite LC-MS/MS assay to understand individual responses in CML and GIST patientsFrank Streit, Lutz Binder, Angelika Hafke, et al.
Hematological Oncology|April 3, 2022
Outcomes of second allogeneic stem cell transplantation and anti-relapse strategies in patients with relapsed/refractory acute myeloid leukemia: A unicentric retrospective analysisEvgenii Shumilov, Justin Hasenkamp, Markus Maulhardt, et al.
Pageof 10